‘Time to finish the job’: One wild polio strain stands in the way of eradication of the disease

global eradication of wild poliovirus type declared on world polio day
Image: Pixabay

The international effort to achieve [polio eradication] passed a major milestone [recently] with the worldwide eradication of wild poliovirus type 3. The announcement, due from the Global Commission for the Certification of the Eradication of Poliomyelitis comes just four years after eradication of wild poliovirus type 2. It leaves only a single strain, wild poliovirus type 1, on the loose. Type 1 is now holed up in the smallest area in the history of the disease—though that area comprises politically and geographically fraught regions of Pakistan and Afghanistan.

Would it be more practical just to back off from the difficult goal of eradication and instead focus on merely controlling the spread of the disease? [The World Health Organization’s Michael] Zaffran cites a 2007 study calculating that the switch from eradication to control would cost $3.5 billion annually—and result in 200,000 cases of polio every year. “If we stop,” he says, “the disease will come back. It will rapidly spread into the Middle East, into Africa and maybe even into Europe and the United States, as we have seen with measles. I truly believe that now is the time to finish the job—and we have all the tools to do it.”

Read full, original post: Two Strains of Polio Down, One to Go

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
global warming
‘Implausible’: Top climate scientists reject worst-case scenario—soaring temperatures and fast-rising sea levels
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.